NextFerm and Soft Gel Technologies collaborate to launch new astaxanthin ingredient
The new astaxanthin derived from yeast fermentation called Astaferm is specifically designed for softgel applications and will be offered as ready-to-use softgels.
Photo © iStockphoto.com/MarsBars
NextFerm (Yokneam, Israel) and Soft Gel Technologies (Commerce, CA) are releasing a new astaxanthin derived from yeast fermentation called Astaferm. The ingredient is specifically designed for softgel applications and will be offered as ready-to-use softgels, with plans to release a special grade for gummies in the future.
“We’re very excited about the way the market is responding to our new approach and messaging, and the backing of a reputable contract manufacturer in Soft Gel means a lot to us,” said Elzaphan Hotam, CEO of NextFerm USA, in a press release. “The addition of a softgel application to our previous launch of gummies adds yet another important segment to our marketing efforts and our reach.”
“For us, we see a great opportunity to introduce a new and fresh approach to what was a completely generic and stagnant market until recently. Astaferm is a non-GMO, sustainable, and non-marine-sourced astaxanthin,” said Steve Holtby, president and CEO of Soft Gel Technologies, Inc., in a press release. “This is a natural and effective product, which offers brands a simple way to differentiate themselves at a competitive price and without compromising on the highest quality standards.”
